Form Type: 4

Accession Number:	0001209191-21-059039
Date:	2021-09-30
Issuer:	KALVISTA PHARMACEUTICALS, INC. (KALV)
Original Submission Date:

Reporting Person:

EDWARDS MARTIN
C/O KALVISTA PHARMACEUTICALS, INC.
55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of Security	Transaction Date	2a. Deemed Execution Date	Transaction Code	Shares	Acquired or Disposed	Price per share	5. Amount of Securities Beneficially Owned Following Reported Transaction	6. Ownership Form Direct or Indirect	Nature of Indirect Ownership

Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security	Conversion or Exercise Price of Derivative Security	Transaction Date	Deemed Execution Date	Transaction Code	Number of Derivative Securities Acquired (A) or Disposed of (D)	Date Exercisable	Expiration Date	Title and Amount of Securities Underlying Derivative Security	Price of Derivative Security	Number of derivative Securities Beneficially Owned Following Reported Transaction(s)	Ownership Form: Direct (D) or Indirect (I)	Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY)	17.45	2021-09-30	deemed execution date	A	10,000 (a)		2031-09-29	common stock 10,000	$17.45	10,000	direct

Footnotes
ID	footnote
f1	the option vests over a 12 month period: 1/12th on october 30, 2021, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.

Elevate your investments